Compuestos de indol y métodos de uso
La invención se refiere a compuestos heterocíclicos, sales farmacéuticamente aceptables de los mismos y preparaciones farmacéuticas de los mismos. También se describen en el presente documento las composiciones y el uso de dichos compuestos en métodos de tratamiento de enfermedades y afecciones medi...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | David BORCHERDING Jinyu LIU Matthieu BARRAGUE Roy VAZ Claude BARBERIS Anatoly RUVINSKY Yi LI Timothy Alan GILLESPY Markus METZ Bradford HIRTH Zhongli GAO Junkai LIAO Sukanthini THURAIRATNAM Alexandre GROSS Andrew GOOD Mark MUNSON Gregory HURLBUT |
| description | La invención se refiere a compuestos heterocíclicos, sales farmacéuticamente aceptables de los mismos y preparaciones farmacéuticas de los mismos. También se describen en el presente documento las composiciones y el uso de dichos compuestos en métodos de tratamiento de enfermedades y afecciones mediadas por una actividad deficiente de CFTR, en particular la fibrosis quística.
The invention relates to heterocyclic compounds, pharmaceutically acceptable salts thereof, and pharmaceutical preparations thereof. Also described herein are compositions and the use of such compounds in methods of treating diseases and conditions mediated by deficient CFTR activity, in particular cystic fibrosis. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CL2024000639A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CL2024000639A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CL2024000639A13</originalsourceid><addsrcrecordid>eNrjZFB1zs8tKE0tLskvVkhJVcjMS8nPUahUyD28siQ_BSJWWpzPw8CalphTnMoLpbkZlN1cQ5w9dFML8uNTiwsSk1PzUkvinX2MDIxMDAwMzIwtHQ2NiVMFAPiXKC4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Compuestos de indol y métodos de uso</title><source>esp@cenet</source><creator>David BORCHERDING ; Jinyu LIU ; Matthieu BARRAGUE ; Roy VAZ ; Claude BARBERIS ; Anatoly RUVINSKY ; Yi LI ; Timothy Alan GILLESPY ; Markus METZ ; Bradford HIRTH ; Zhongli GAO ; Junkai LIAO ; Sukanthini THURAIRATNAM ; Alexandre GROSS ; Andrew GOOD ; Mark MUNSON ; Gregory HURLBUT</creator><creatorcontrib>David BORCHERDING ; Jinyu LIU ; Matthieu BARRAGUE ; Roy VAZ ; Claude BARBERIS ; Anatoly RUVINSKY ; Yi LI ; Timothy Alan GILLESPY ; Markus METZ ; Bradford HIRTH ; Zhongli GAO ; Junkai LIAO ; Sukanthini THURAIRATNAM ; Alexandre GROSS ; Andrew GOOD ; Mark MUNSON ; Gregory HURLBUT</creatorcontrib><description>La invención se refiere a compuestos heterocíclicos, sales farmacéuticamente aceptables de los mismos y preparaciones farmacéuticas de los mismos. También se describen en el presente documento las composiciones y el uso de dichos compuestos en métodos de tratamiento de enfermedades y afecciones mediadas por una actividad deficiente de CFTR, en particular la fibrosis quística.
The invention relates to heterocyclic compounds, pharmaceutically acceptable salts thereof, and pharmaceutical preparations thereof. Also described herein are compositions and the use of such compounds in methods of treating diseases and conditions mediated by deficient CFTR activity, in particular cystic fibrosis.</description><language>spa</language><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240913&DB=EPODOC&CC=CL&NR=2024000639A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25568,76551</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240913&DB=EPODOC&CC=CL&NR=2024000639A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>David BORCHERDING</creatorcontrib><creatorcontrib>Jinyu LIU</creatorcontrib><creatorcontrib>Matthieu BARRAGUE</creatorcontrib><creatorcontrib>Roy VAZ</creatorcontrib><creatorcontrib>Claude BARBERIS</creatorcontrib><creatorcontrib>Anatoly RUVINSKY</creatorcontrib><creatorcontrib>Yi LI</creatorcontrib><creatorcontrib>Timothy Alan GILLESPY</creatorcontrib><creatorcontrib>Markus METZ</creatorcontrib><creatorcontrib>Bradford HIRTH</creatorcontrib><creatorcontrib>Zhongli GAO</creatorcontrib><creatorcontrib>Junkai LIAO</creatorcontrib><creatorcontrib>Sukanthini THURAIRATNAM</creatorcontrib><creatorcontrib>Alexandre GROSS</creatorcontrib><creatorcontrib>Andrew GOOD</creatorcontrib><creatorcontrib>Mark MUNSON</creatorcontrib><creatorcontrib>Gregory HURLBUT</creatorcontrib><title>Compuestos de indol y métodos de uso</title><description>La invención se refiere a compuestos heterocíclicos, sales farmacéuticamente aceptables de los mismos y preparaciones farmacéuticas de los mismos. También se describen en el presente documento las composiciones y el uso de dichos compuestos en métodos de tratamiento de enfermedades y afecciones mediadas por una actividad deficiente de CFTR, en particular la fibrosis quística.
The invention relates to heterocyclic compounds, pharmaceutically acceptable salts thereof, and pharmaceutical preparations thereof. Also described herein are compositions and the use of such compounds in methods of treating diseases and conditions mediated by deficient CFTR activity, in particular cystic fibrosis.</description><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFB1zs8tKE0tLskvVkhJVcjMS8nPUahUyD28siQ_BSJWWpzPw8CalphTnMoLpbkZlN1cQ5w9dFML8uNTiwsSk1PzUkvinX2MDIxMDAwMzIwtHQ2NiVMFAPiXKC4</recordid><startdate>20240913</startdate><enddate>20240913</enddate><creator>David BORCHERDING</creator><creator>Jinyu LIU</creator><creator>Matthieu BARRAGUE</creator><creator>Roy VAZ</creator><creator>Claude BARBERIS</creator><creator>Anatoly RUVINSKY</creator><creator>Yi LI</creator><creator>Timothy Alan GILLESPY</creator><creator>Markus METZ</creator><creator>Bradford HIRTH</creator><creator>Zhongli GAO</creator><creator>Junkai LIAO</creator><creator>Sukanthini THURAIRATNAM</creator><creator>Alexandre GROSS</creator><creator>Andrew GOOD</creator><creator>Mark MUNSON</creator><creator>Gregory HURLBUT</creator><scope>EVB</scope></search><sort><creationdate>20240913</creationdate><title>Compuestos de indol y métodos de uso</title><author>David BORCHERDING ; Jinyu LIU ; Matthieu BARRAGUE ; Roy VAZ ; Claude BARBERIS ; Anatoly RUVINSKY ; Yi LI ; Timothy Alan GILLESPY ; Markus METZ ; Bradford HIRTH ; Zhongli GAO ; Junkai LIAO ; Sukanthini THURAIRATNAM ; Alexandre GROSS ; Andrew GOOD ; Mark MUNSON ; Gregory HURLBUT</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CL2024000639A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2024</creationdate><topic>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>David BORCHERDING</creatorcontrib><creatorcontrib>Jinyu LIU</creatorcontrib><creatorcontrib>Matthieu BARRAGUE</creatorcontrib><creatorcontrib>Roy VAZ</creatorcontrib><creatorcontrib>Claude BARBERIS</creatorcontrib><creatorcontrib>Anatoly RUVINSKY</creatorcontrib><creatorcontrib>Yi LI</creatorcontrib><creatorcontrib>Timothy Alan GILLESPY</creatorcontrib><creatorcontrib>Markus METZ</creatorcontrib><creatorcontrib>Bradford HIRTH</creatorcontrib><creatorcontrib>Zhongli GAO</creatorcontrib><creatorcontrib>Junkai LIAO</creatorcontrib><creatorcontrib>Sukanthini THURAIRATNAM</creatorcontrib><creatorcontrib>Alexandre GROSS</creatorcontrib><creatorcontrib>Andrew GOOD</creatorcontrib><creatorcontrib>Mark MUNSON</creatorcontrib><creatorcontrib>Gregory HURLBUT</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>David BORCHERDING</au><au>Jinyu LIU</au><au>Matthieu BARRAGUE</au><au>Roy VAZ</au><au>Claude BARBERIS</au><au>Anatoly RUVINSKY</au><au>Yi LI</au><au>Timothy Alan GILLESPY</au><au>Markus METZ</au><au>Bradford HIRTH</au><au>Zhongli GAO</au><au>Junkai LIAO</au><au>Sukanthini THURAIRATNAM</au><au>Alexandre GROSS</au><au>Andrew GOOD</au><au>Mark MUNSON</au><au>Gregory HURLBUT</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Compuestos de indol y métodos de uso</title><date>2024-09-13</date><risdate>2024</risdate><abstract>La invención se refiere a compuestos heterocíclicos, sales farmacéuticamente aceptables de los mismos y preparaciones farmacéuticas de los mismos. También se describen en el presente documento las composiciones y el uso de dichos compuestos en métodos de tratamiento de enfermedades y afecciones mediadas por una actividad deficiente de CFTR, en particular la fibrosis quística.
The invention relates to heterocyclic compounds, pharmaceutically acceptable salts thereof, and pharmaceutical preparations thereof. Also described herein are compositions and the use of such compounds in methods of treating diseases and conditions mediated by deficient CFTR activity, in particular cystic fibrosis.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | spa |
| recordid | cdi_epo_espacenet_CL2024000639A1 |
| source | esp@cenet |
| subjects | ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | Compuestos de indol y métodos de uso |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T13%3A35%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=David%20BORCHERDING&rft.date=2024-09-13&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECL2024000639A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |